Aprea Therapeutics Inc (APRE) financials · $10.4M cap
Aprea Therapeutics Inc (APRE) $10.4M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Income | -$13.2M | -$14.3M |
| Net Income | -$12.6M | -$13.0M |
| EPS (Diluted) | $-1.93 | $-2.45 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $15.9M | $24.0M |
| Current Assets | $15.6M | $23.6M |
| Cash & Equivalents | $14.6M | $22.8M |
| Inventory | $0 | $0 |
| PP&E | $59.8K | $81.5K |
| Total Liabilities | $15.9M | $24.0M |
| Current Liabilities | $2.8M | $3.4M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $12.4M | $19.3M |
| Retained Earnings | -$333.6M | -$321.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$12.9M | -$13.6M |
| CapEx | $0 | $15.5K |
| Investing Cash Flow | $0 | -$15.5K |
| Financing Cash Flow | $4.6M | $14.8M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | $0 | $0 |
| Free Cash Flow | $0 | -$13.5M |
FAQ
What is APRE P/E and revenue?
Aprea Therapeutics Inc (APRE) $10.4M cap.
What is APRE revenue?
Aprea Therapeutics Inc last cached revenue is $0 (FY2025).
Is APRE profitable?
Aprea Therapeutics Inc last cached net income is -$12.6M.
What are APRE total assets?
Aprea Therapeutics Inc last cached total assets are $15.9M.
What is APRE free cash flow?
Aprea Therapeutics Inc last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.